The Lubrizol Corporation announced the launch of a flame-retardant thermoplastic polyurethane (TPU) product suitable for medical applications. Developed by Lubrizol LifeScience Polymers, this product is the first of its kind to feature high flame properties, low halogen content and a soft, matte or gloss finish.
The unique design of the UniFlow Dual Entry Hood features safety glass sashes front and rear that allows observers a clear view as well as easy access to procedures. Ideal for schools and industrial where additional access is required. Fume Hood is equipped with a vapor proof light fixture and switch. All electrical components and services are UL and CSA listed.
Johnson Electric announced a new magnetic latching solenoid platform for compact locking mechanisms. Locks of all varieties including those found in vaults, safes, medical devices, data storage and industrial equipment require compact and powerful solenoids in electrically coded or biometric access systems.
Based on a scientific breakthrough developed at Caltech, the Department of Defense, and NASA, Liquidmetal Technologies has introduced an amorphous metal alloy that can be used in the production of highly complex parts via an efficient injection-molding process.
In this blog, we’ll explore challenges associated with conducting reliable usability evaluations and offer insights as to how to overcome these challenges. We’ll also discuss how to improve usability testing practices to ensure we are identifying the most important issues.
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its next-generation Ellipse™ and SJM Assura™ portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The new devices are designed to lower the risk of lead abrasion and to ensure high-voltage therapy delivery.
Diagnostic technology covers a broad range of equipment, tests, and medical fields, and recent advancements in technique and materials means that innovations are widespread and growing rapidly. Though economic conditions are preventing huge advancements in diagnostic imaging—if hospitals can’t afford the new technology, there is no point in designing it—the medical imaging community is focusing on refinement, rather than redesign.
Over the next three months, Seapine Software will be polling medical device developers for its 2013 State of Medical Device Development Survey. The online survey will establish industry benchmarks and identify the challenges facing the development of new healthcare technologies.
Next-Generation Clot Retrieval Technology Improves Patient Outcomes vs. First- Generation Devices, Say Leading Stroke PhysiciansJune 11, 2013 11:59 am | by Covidien | News | Comments
Covidien brought together six of the world’s prominent thought-leaders in stroke at the 2013 European Stroke Conference. At a Covidien-sponsored symposium, the stroke experts presented and discussed data underscoring the benefits of endovascular therapy in treating acute ischemic stroke and, particularly, the important role that new devices play when this procedure is performed to remove blood clots from large vessels in the brain.
Wake Forest Baptist Medical Center doctors have found that using stress cardiac magnetic resonance (CMR) imaging in an Emergency Department observation unit to care for patients with acute chest pain is a win-win - for the patient and the institution.
Just a few years ago, integrated positron emission tomography and magnetic resonance (PET/MR) imaging was found only in research institutes, but little by little the technology has expanded into clinical practice. This is especially true for cardiac indications, for which the highly sensitive soft tissue contrast of MR and the functional and metabolic imaging of PET are particularly valuable.
Coronary artery disease (CAD) is one of the world’s most prevalent and silent killers. Positron emission tomography (PET), which images miniscule abnormalities in cellular metabolism, can tip off clinicians about cardiac disasters waiting to happen—including sudden death from a heart attack—better than standard angiography, researchers revealed at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.
A relatively new weapon in the fight against childhood brain cancer has emerged that improves upon standard magnetic resonance imaging (MRI) by providing information about tumor metabolism and extent of cancer in children diagnosed with glioma, a growth caused by the abnormal division of glial cells in the brain, say researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.
One of the biggest hurdles of hybrid positron emission tomography and magnetic resonance (PET/MR) imaging is the prevalence of motion artifacts—blurring and ghostly visual anomalies caused by patient motion on the table during imaging. An MR technology has now been designed for PET/MR that employs tiny radiofrequency solenoids—metal coils integrated into hardware placed on the body—to track motion from those who do not or cannot stay put.
The Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting marks the unveiling of the successful application of a new preclinical hybrid molecular imaging system—single photon emission tomography and magnetic resonance—which has exceptional molecular imaging capabilities in terms of potential preclinical and clinical applications, technological advancement at a lower cost, and reduction of patient exposure to radiation.